Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018871 |
---|---|
Receipt number | R000020114 |
Scientific Title | Effects of Dapagliflozin on Hyperlipidemia, Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS study) |
Date of disclosure of the study information | 2015/09/01 |
Last modified on | 2020/09/09 10:17:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/09/01 06:56:05 | ||
2 | Update | 2015/09/02 12:01:48 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2018/08/03 05:41:43 | Recruitment status |
|
4 | Update | 2020/09/09 10:00:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Institute Institute Organization Research ethics review Organization Organization Address Address Tel |
|
5 | Update | 2020/09/09 10:14:28 | Number of participants that the trial has enrolled Results |
|
6 | Update | 2020/09/09 10:17:06 | Recruitment status Date of IRB Last follow-up date Date analysis concluded |